Hypermetabolism in the hippocampal formation of cognitively impaired patients 
indicates detrimental maladaptation

Apostolova, Ivayla; Lange, Catharina; Mäurer, Anja; Suppa, Per; Spies, Lothar; Grothe, Michel J.; Nierhaus, Till; Fiebach, Jochen B.; Steinhagen-Thiessen, Elisabeth; Buchert, R.; Alzheimer's Disease Neuroimaging Initiative

doi:10.1016/j.neurobiolaging.2018.01.002

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation

MPS-Authors

/persons/resource/persons19892

Nierhaus, Till
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;
Center for Cognitive Neuroscience Berlin (CCNB), FU Berlin, Germany;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Apostolova, I., Lange, C., Mäurer, A., Suppa, P., Spies, L., Grothe, M. J., et al. (2018). Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation. Neurobiology of Aging, 65, 41-50. doi:10.1016/j.neurobiolaging.2018.01.002.

Cite as: https://hdl.handle.net/21.11116/0000-0000-82D4-D

Abstract

Structural deterioration and volume loss of the hippocampal formation is observed in many diseases associated with memory decline. Paradoxically, glucose metabolism of the hippocampal formation can be increased at the same time. This might be a consequence of compensatory (beneficial) or maladaptive (detrimental) mechanisms. Aim of this study was to differentiate between compensation and maladaptation by analyzing the association between glucose metabolism in the hippocampal formation measured by positron emission tomography with the glucose analogue 18F-fluorodeoxyglucose and cognitive performance as characterized by the extended Consortium to Establish a Registry for Alzheimer's Disease test battery in a sample of 87 patients (81.8 ± 5.4 years) with mild cognitive impairment or mild dementia and varying etiological diagnoses. Glucose metabolism in the hippocampal formation was negatively correlated with the performance in several cognitive subdomains, most pronounced for verbal semantic fluency, independent of overall neuronal dysfunction, presence of clinical Alzheimer's disease, and overall cognitive performance. This finding provides evidence that increased glucose metabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation rather than a beneficial compensatory reaction. Excess glucose metabolism in the hippocampal formation might be a useful therapeutic target in these patients.